195 related articles for article (PubMed ID: 29859273)
1. miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3.
Zurawek M; Dzikiewicz-Krawczyk A; Izykowska K; Ziolkowska-Suchanek I; Skowronska B; Czainska M; Podralska M; Fichna P; Przybylski G; Fichna M; Nowak J
Diabetes Res Clin Pract; 2018 Aug; 142():146-153. PubMed ID: 29859273
[TBL] [Abstract][Full Text] [Related]
2. miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.
Salem M; Shan Y; Bernaudo S; Peng C
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013711
[TBL] [Abstract][Full Text] [Related]
3. MiR-885-3p is down-regulated in peripheral blood mononuclear cells from T1D patients and regulates the inflammatory response via targeting TLR4/NF-κB signaling.
Zhang X; Gu H; Wang L; Huang F; Cai J
J Gene Med; 2020 Jan; 22(1):e3145. PubMed ID: 31763742
[TBL] [Abstract][Full Text] [Related]
4. Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146.
Yang M; Ye L; Wang B; Gao J; Liu R; Hong J; Wang W; Gu W; Ning G
J Diabetes; 2015 Mar; 7(2):158-65. PubMed ID: 24796653
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of
Zurawek M; Fichna M; Fichna P; Czainska M; Rozwadowska N
J Immunol Res; 2020; 2020():9484015. PubMed ID: 32851102
[TBL] [Abstract][Full Text] [Related]
6. microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.
Pan S; Li M; Yu H; Xie Z; Li X; Duan X; Huang G; Zhou Z
Acta Diabetol; 2021 Jan; 58(1):63-72. PubMed ID: 32815005
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29c-3p participates in insulin function to modulate polycystic ovary syndrome via targeting Forkhead box O 3.
Chen H; Fu Y; Guo Z; Zhou X
Bioengineered; 2022 Feb; 13(2):4361-4371. PubMed ID: 35142592
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: Association with ongoing islet autoimmunity.
Wang G; Gu Y; Xu N; Zhang M; Yang T
Biochem Biophys Res Commun; 2018 Apr; 498(3):382-387. PubMed ID: 28733034
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes.
Santos AS; Cunha Neto E; Fukui RT; Ferreira LRP; Silva MER
Front Immunol; 2019; 10():1637. PubMed ID: 31396209
[TBL] [Abstract][Full Text] [Related]
10. Profiling of circulating microRNAs in children with recent onset of type 1 diabetes.
Erener S; Marwaha A; Tan R; Panagiotopoulos C; Kieffer TJ
JCI Insight; 2017 Feb; 2(4):e89656. PubMed ID: 28239651
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-148a-3p promotes survival and migration of endothelial cells isolated from Apoe deficient mice through restricting circular RNA 0003575.
Shang L; Quan A; Sun H; Xu Y; Sun G; Cao P
Gene; 2019 Aug; 711():143948. PubMed ID: 31255737
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetes.
Azhir Z; Dehghanian F; Hojati Z
Mol Biol Rep; 2018 Dec; 45(6):1973-1980. PubMed ID: 30194557
[TBL] [Abstract][Full Text] [Related]
14. Expression Pattern of microRNAs, miR-21, miR-155 and miR-338 in Patients with Type 1 Diabetes.
Mostahfezian M; Azhir Z; Dehghanian F; Hojati Z
Arch Med Res; 2019 Apr; 50(3):79-85. PubMed ID: 31495393
[TBL] [Abstract][Full Text] [Related]
15. Post-transcriptional control of candidate risk genes for type 1 diabetes by rare genetic variants.
de Jong VM; Zaldumbide A; van der Slik AR; Persengiev SP; Roep BO; Koeleman BP
Genes Immun; 2013 Jan; 14(1):58-61. PubMed ID: 22932817
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients.
Shang Z; Li H
J Dermatol; 2017 Oct; 44(10):1138-1144. PubMed ID: 28500632
[TBL] [Abstract][Full Text] [Related]
17. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.
Collares CV; Evangelista AF; Xavier DJ; Rassi DM; Arns T; Foss-Freitas MC; Foss MC; Puthier D; Sakamoto-Hojo ET; Passos GA; Donadi EA
BMC Res Notes; 2013 Nov; 6():491. PubMed ID: 24279768
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells.
Grieco FA; Sebastiani G; Juan-Mateu J; Villate O; Marroqui L; Ladrière L; Tugay K; Regazzi R; Bugliani M; Marchetti P; Dotta F; Eizirik DL
Diabetes; 2017 Jan; 66(1):100-112. PubMed ID: 27737950
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes.
Salas-Pérez F; Codner E; Valencia E; Pizarro C; Carrasco E; Pérez-Bravo F
Immunobiology; 2013 May; 218(5):733-7. PubMed ID: 22999472
[TBL] [Abstract][Full Text] [Related]
20. Expression of B7 and CD28 family genes in newly diagnosed type 1 diabetes.
Pruul K; Kisand K; Alnek K; Metsküla K; Heilman K; Peet A; Varik K; Uibo R
Hum Immunol; 2013 Oct; 74(10):1251-7. PubMed ID: 23911738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
